Lung cancer incidence trends in Uruguay 1990–2014: An age-period-cohort analysis

Alonso, Rafael; Piñeros, Marion; Laversanne, Mathieu; Musetti, Carina; Garau, Mariela; Barrios, Enrique; Bray, Freddie

doi:10.1016/j.canep.2018.04.012

Cited by 31 publications

(33 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There is a 20‐fold variation in lung cancer rates by region, which largely reflects the maturity of the tobacco epidemic and differentials in the historic patterns of tobacco exposure, including intensity and duration of smoking, type of cigarettes, and degree of inhalation. Among men, a diminution in smoking prevalence, followed by a peak and decline in lung cancer rates in the same generations, was first observed in several high‐income countries where smoking was first established, including the United Kingdom, the United States, Finland, Australia, New Zealand, the Netherlands, Singapore, and (more recently) Germany, Uruguay, and the remaining Nordic countries . A recent analysis of incidence trends in 26 European countries revealed that rates in men aged 35 to 64 years have been decreasing in recent years, including Eastern European countries, although rates were still increasing in Bulgaria …”

Section: Resultsmentioning

confidence: 99%

“…Below, we describe the variations in sex-specific incidence and mortality rates by world region for 16 of these cancer types (Figs. [8][9][10][11][12][13][14][15][16][17][18][19][20][21].…”

Section: Cancer Incidence and Death Rates By World Regionmentioning

confidence: 99%

“…Among men, a diminution in smoking prevalence, followed by a peak and decline in lung cancer rates in the same generations, was first observed in several high-income countries where smoking was first established, including the United Kingdom, the United States, Finland, Australia, New Zealand, the Netherlands, Singapore, and (more recently) Germany, Uruguay, and the remaining Nordic countries. 15,16 A recent analysis of incidence trends in 26 European countries revealed that rates in men aged 35 to 64 years have been decreasing in recent years, including Eastern European countries, although rates were still increasing in Bulgaria. 17 Among women, the epidemic is less advanced and, in contrast to men, most countries are still observing a rising trend in incidence, 17,18 and only a relatively few populations (eg, the United States [whites] and possibly the United Kingdom) are showing signs of a peak and decline among recent birth cohorts.…”

Section: Lung Cancermentioning

confidence: 99%

See 2 more Smart Citations

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray

Ferlay

Soerjomataram

et al. 2018

CA A Cancer J Clinicians

Self Cite

68,193

238

51,720

View full text Add to dashboard Cite

This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer is the most commonly diagnosed cancer (11.6% of the total cases) and the leading cause of cancer death (18.4% of the total cancer deaths), closely followed by female breast cancer (11.6%), prostate cancer (7.1%), and colorectal cancer (6.1%) for incidence and colorectal cancer (9.2%), stomach cancer (8.2%), and liver cancer (8.2%) for mortality. Lung cancer is the most frequent cancer and the leading cause of cancer death among males, followed by prostate and colorectal cancer (for incidence) and liver and stomach cancer (for mortality). Among females, breast cancer is the most commonly diagnosed cancer and the leading cause of cancer death, followed by colorectal and lung cancer (for incidence), and vice versa (for mortality); cervical cancer ranks fourth for both incidence and mortality. The most frequently diagnosed cancer and the leading cause of cancer death, however, substantially vary across countries and within each country depending on the degree of economic development and associated social and life style factors. It is noteworthy that high-quality cancer registry data, the basis for planning and implementing evidence-based cancer control programs, are not available in most low- and middle-income countries. The Global Initiative for Cancer Registry Development is an international partnership that supports better estimation, as well as the collection and use of local data, to prioritize and evaluate national cancer control efforts. CA: A Cancer Journal for Clinicians 2018;0:1-31. © 2018 American Cancer Society.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Below, we describe the variations in sex-specific incidence and mortality rates by world region for 16 of these cancer types (Figs. [8][9][10][11][12][13][14][15][16][17][18][19][20][21].…”

Section: Cancer Incidence and Death Rates By World Regionmentioning

confidence: 99%

Section: Lung Cancermentioning

confidence: 99%

See 1 more Smart Citation

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Bray

Ferlay

Soerjomataram

et al. 2018

CA A Cancer J Clinicians

Self Cite

68,193

238

51,720

View full text Add to dashboard Cite

show abstract

“…tobacco prevalence in both countries, as reported previously. 14,15 In the US, the declining rates in both sexes, first observed in males in the 1990s and in females in the 2000s is driven by the decreasing tobacco prevalence reported by Thun and colleagues, 13 with an approximate 20 year lag between the peaks of smoking prevalence and lung cancer mortality rates. In Central and South America, the tobacco epidemic was initiated years later; Costa Rica and Colombia have seen decreasing incidence rates by 2000 and 1990 respectively, while rates in Ecuador have stabilized in men.…”

Section: Figure 2 A) Estimated Lung Cancer Incidence Rates (Asr Per mentioning

confidence: 98%

The descriptive epidemiology of lung cancer and tobacco control: a global overview 2018

2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…Infortunadamente, debido a los síntomas inespecíficos de esta enfermedad en sus estadios tempranos, para cuando los pacientes acuden a la consulta generalmente el cáncer de (45) pulmón se encuentra en estadio IIIB o IV, que implica una pobre sobrevida a cinco años . Realizando la comparación del tipo histológico con tabaquismo no se relaciona con la carga tabáquica a diferencia de referencias mundiales donde la relación de carga tabáquica y tipo histológico es con SCLC en un (44,(46)(47)(48)(49) 95%…”

Section: Masculinaunclassified

Etiological factors and characterization of patients with lung cancer at the National Cancer Institute, Paraguay

León

Agüero

Gauna

et al. 2020

Rev. virtual Soc. Parag. Med. Int

View full text Add to dashboard Cite

Introducción: el cáncer de pulmón es un problema de Salud Pública en el mundo y en nuestro país por su alta mortalidad e incidencia. Los carcinógenos medioambientales y el tabaquismo están directamente relacionados como factores de riesgo. Objetivo: Caracterizar los factores etiológicos de fumador activo y carcinógenos medioambientales de los pacientes con cáncer de pulmón detectados durante 9 años en el Instituto Nacional del Cáncer, Paraguay. Metodología: estudio observacional retrospectivo descriptivo analítico de una base de datos del período 2004-2013. Las variables medidas fueron datos demográficos, carga tabáquica, tabaquismo, la exposición a carcinógenos medioambientales categoría I. Resultados: se incluyeron 478 pacientes con cáncer pulmonar, 88,1% de sexo masculino y 11,9% femenino. La edad promedio del sexo masculino fue 60±10 años y del sexo femenino 58±12 años. La prevalencia de exposición carcinógenos medioambientales categoría I fue 36,90%. La media del índice tabáquico fue 4,48±20. El modelo de regresión lineal múltiple entre exposición ambiental, tabaquismo y tipo histológico para predecir la severidad clínica fue 3,6%. En el análisis de regresión logística de la relación de tipos histológicos con tabaquismo, género y exposición ambiental no mejoran el modelo de predicción. Conclusiones: Los factores etiológicos relacionados con carcinógenos medioambientales estuvieron presentes en más de un tercio de la población, el hábito tabáquico es mayor en hombres que en mujeres. El tipo histológico más frecuente para ambos sexos, con y sin el hábito tabáquico, es el carcinoma de células no pequeñas.

show abstract

Lung cancer incidence trends in Uruguay 1990–2014: An age-period-cohort analysis

Cited by 31 publications

References 14 publications

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

The descriptive epidemiology of lung cancer and tobacco control: a global overview 2018

Etiological factors and characterization of patients with lung cancer at the National Cancer Institute, Paraguay

Contact Info

Product

Resources

About